Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Different resuscitation strategies and novel pharmacologic treatment with valproic acid in traumatic brain injury

Research output: Contribution to journalReviewpeer-review

DOI

  1. Pharmacological sex hormone manipulation as a risk model for depression

    Research output: Contribution to journalReviewpeer-review

  2. Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Diverse roles of extracellular calcium-sensing receptor in the central nervous system

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Ketamine for rapid sequence intubation in adult trauma patients: A retrospective observational study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Smoking and risk of surgical bleeding: nationwide analysis of 5,452,411 surgical cases

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Identification of a new genetic variant associated with cholecystitis: a multicenter genome-wide association study

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Red blood cell transfusion in surgery: an observational study of the trends in the USA from 2011 to 2016

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Simone E Dekker
  • Vahagn C Nikolian
  • Martin Sillesen
  • Ted Bambakidis
  • Patrick Schober
  • Hasan B Alam
View graph of relations

Traumatic brain injury (TBI) is a leading cause of death in young adults, and effective treatment strategies have the potential to save many lives. TBI results in coagulopathy, endothelial dysfunction, inflammation, cell death, and impaired epigenetic homeostasis, ultimately leading to morbidity and/or mortality. Commonly used resuscitation fluids such as crystalloids or colloids have several disadvantages and might even be harmful when administered in large quantities. There is a need for next-generation treatment strategies (especially in the prehospital setting) that minimize cellular damage, improve survival, and enhance neurological recovery. Pharmacologic treatment with histone deacetylase inhibitors, such as valproic acid, has shown promising results in animal studies of TBI and may therefore be an excellent example of next-generation therapy. This review briefly describes traditional resuscitation strategies for TBI combined with hemorrhagic shock and describes preclinical studies on valproic acid as a new pharmacologic agent in the treatment of TBI. It finally discusses limitations and future directions on the use of histone deacetylase inhibitors for the treatment of TBI.

Original languageEnglish
JournalJournal of Neuroscience Research
Volume96
Issue number4
Pages (from-to)711-719
Number of pages9
ISSN0360-4012
DOIs
Publication statusPublished - Apr 2018

ID: 56536222